Discover free eBooks, guides and med spa templates on our new resources page

ICD-11

ICD-11 Codes
for MA12.3 - Finding of psychotropic drug in blood
Teodor Jurukovski January 1, 1970
Fact checked by: Teodor Jurukovski
Use Code

Understanding the Presence of Psychotropic Drugs in Blood

The finding of a psychotropic drug in the blood refers to the laboratory detection of substances that influence mental state, mood, or behaviour. This finding is typically part of a broader clinical evaluation and may indicate recent substance use, adherence to prescribed medication, or potential toxicity. It is not a diagnosis in itself but a clinical observation that requires interpretation within the patient's overall health context.

Identifying Psychotropic Drugs in Blood Samples

The presence of psychotropic drugs in the bloodstream is identified through specific laboratory analyses. These may include toxicology screens or therapeutic drug monitoring, which examine blood samples to detect and quantify various prescribed or illicit psychoactive substances. These tests are crucial for confirming the presence of specific drugs.

Alternative Terms for Psychotropic Drug Detection

This clinical finding may be referred to by several alternative terms, including:

  • Psychotropic substance detection in blood
  • Blood test for psychiatric medication
  • Detection of psychoactive substances
  • Drug screening (blood)

ICD-11 Coding for Psychotropic Drug Findings

The International Classification of Diseases, 11th Revision (ICD-11) provides specific codes for medical findings. The ICD-11 code for the finding of a psychotropic drug in the blood is MA12.3. This official condition name, 'Finding of psychotropic drug in blood', is used in medical documentation to accurately record the results of laboratory tests. Healthcare providers utilise this ICD-11 code for precise medical coding and reporting purposes, ensuring clear communication within the healthcare system.

Billable Status of ICD-11 Code MA12.3

The ICD-11 code MA12.3, representing the finding of a psychotropic drug in the blood, is primarily used for reporting and documentation within a clinical setting. Its status as a billable code often depends on specific payer policies and the context of the clinical services provided alongside the drug detection test. Providers should verify billing guidelines with relevant insurance carriers.

When to Consult a Healthcare Professional

If a blood test indicates the presence of a psychotropic drug, or if there are concerns regarding medication levels, potential side effects, or substance use, it is essential to consult with a qualified healthcare provider. A physician can interpret these laboratory results within the patient's complete medical history and treatment plan, offering appropriate guidance and management strategies.

Frequently asked questions

What is the ICD-11 classification for 'Finding of psychotropic drug in blood'?
The ICD-11 code for 'Finding of psychotropic drug in blood' is MA12.3.
What does the ICD-11 code MA12.3 signify?
MA12.3 signifies the finding of a psychotropic drug in the blood.
When is the ICD-11 code MA12.3 documented?
The ICD-11 code MA12.3 is documented when a psychotropic drug is found in the blood.
What is the distinction between MA12.3 and other specific drug findings in blood codes within ICD-11?
MA12.3 is specifically for the finding of a psychotropic drug in the blood. Other codes within the MA12 block may be used for specific types of drugs, such as opiates (MA12.0), cocaine (MA12.1), or hallucinogens (MA12.2). MA12.Y is available for other specified clinical findings of drugs, medicaments, and biological substances in blood.
×